Urabe F. Editorial Comment on Bayesian Reanalysis of Enzalutamide Plus Androgen Deprivation Therapy in Japanese Patients With Metastatic Hormone-Sensitive Prostate Cancer: A Methodological Complement to Frequentist Analysis From the ARCHES Trial. Int J Urol 2025 Oct 26. doi: 10.1111/iju.70269.
PMID: 41139864